v3.26.3
Temporary Equity and Stockholders’ Equity (Deficit) (Tables)
12 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Schedule of Unvested Series C Convertible Preferred Stock

 

       Weighted Average 
   Number of   Grant Date 
Non-Vested Shares  Shares   Fair Value 
June 30, 2024   -   $- 
Granted   94,250    0.0068 
Vested   (37,300)   0.0068 
Cancelled/Forfeited   -    - 
June 30, 2025   56,950   $0.0068 
Granted   -      
Vested   (49,096)     
Cancelled/Forfeited   -      
June 30, 2026   7,854   $0.0068 
           
Unrecognized compensation  $320,450      
           
Weighted average remaining period (years)   0.42      
Schedule of Revenue Based Equity Awards

 

Company Revenue   Restricted Stock Award (% of equity) 
      
$50,000,000    3.0%
$100,000,000    3.5%
$150,000,000    4.0%
$200,000,000    4.5%
$300,000,000    5.0%
Schedule of EBITDA Based Equity Awards

 

Company EBITDA   Restricted Stock Award (% of equity) 
$1,000,000    2%
$3,000,000    3%
$5,000,000    4%
$10,000,000    5%
$20,000,000    6%
$30,000,000    7%
$50,000,000    8%
$100,000,000    10%
Schedule of Stock Warrant Activity

Warrant activity for the years ended June 30, 2026 and 2025 are summarized as follows:

 

           Weighted     
           Average     
       Weighted   Remaining   Aggregate 
   Number of   Average   Contractual   Intrinsic 
Warrants  Warrants   Exercise Price   Term (Years)   Value 
Outstanding - June 30, 2024   191,799,274   $0.24    3.21   $6,140,000 
Exercisable - June 30, 2024   191,799,274   $0.24    3.21   $6,140,000 
Granted   2,068,869   $0.10           
Exercised   -                
Cancelled/Forfeited   (1,871,800)  $0.16           
Outstanding - June 30, 2025   191,996,343   $0.05    2.21   $- 
Exercisable - June 30, 2025   191,996,343   $0.05    2.21   $- 
Granted   30,000,000   $0.02           
Exercised   (3,844,697)  $0.03           
Cancelled/Forfeited   (32,842,911)  $0.10           
Outstanding - June 30, 2026   185,308,735   $0.03    1.95   $474,464 
Exercisable - June 30, 2026   185,308,735   $0.03    1.95   $474,464 
Schedule of Fair Value of Warrant

 

   October 8, 2025   June 30, 2026 
Exercise price  $0.10   $0.02 
Expected term (years)   5.00    4.28 
Expected volatility   183.1%   199.6%
Expected dividends   0%   0%
Risk free interest rate   3.72%   3.72%

Schedule of Stock Option Transactions

Stock option transactions for the year ended June 30, 2026 are summarized as follows:

 

           Weighted   Weighted     
           Average   Average     
       Weighted   Remaining   Grant   Aggregate 
   Number of   Average   Contractual   Date   Intrinsic 
Stock Options  Options   Exercise Price   Term (Years)   Fair Value   Value 
Outstanding - June 30, 2025   -   $-    -    -   $- 
Granted   34,630,305   $0.033         0.0271      
Exercised   -   $-                
Cancelled/Forfeited   -   $-                
Outstanding - June 30, 2026   34,630,305   $0.033    9.76        $17,315 
Vested and Exercisable - June 30, 2026   12,757,576   $0.033    9.84        $6,379 
Unvested - June 30, 2026   21,872,729   $0.033    9.71        $10,936 
Schedule of Black-Scholes Option Pricing Model

 

Exercise price  $0.033 
Expected volatility   173.4% - 221.8%
Expected dividend yield   0.0%
Expected term in years   2.75 - 6.30 
Risk-free interest rate   3.91% - 4.11%
Schedule of Unvested Stock Option Activity

The following is a summary of the Company’s unvested stock option activity for the year ended June 30, 2026:

 

       Weighted Average 
   Number of   Grant Date 
Non-Vested Stock Options  Options   Fair Value 
June 30, 2025   -   $- 
Granted   34,630,305    0.0271 
Vested   (12,757,576)   0.0271 
Cancelled/Forfeited   -    - 
June 30, 2026   21,872,729   $0.0271 
           
Unrecognized compensation  $498,378      
           
Weighted average remaining period (years)   1.24      
Schedule of Unvested Stock Option

The unvested stock options are scheduled to vest as follows:

 

Years ended June 30,  Quantity of Options 
2027   10,418,185 
2028   8,181,814 
2029   3,272,730 
    21,872,729 
Schedule of Stock Options Granted

The following is a detail of the stock options granted during the year ended June 30, 2026:

 

   Grant Date  Quantity   Vested and Exercisable   Unvested   Fair Value   Compensation Expense 
Employees  May 1, 2026   19,181,820    7,136,364    12,045,456   $518,876   $241,396 
Consultants  May 1, 2026   14,848,485    5,621,212    9,227,273    401,445    196,275 
Advisory Board Member  June 1, 2026   600,000         600,000    17,665    1,937 
       34,630,305    12,757,576    21,872,729   $937,986   $439,608 
                             
Third Party      28,569,699    9,575,758    18,993,941   $774,329      
Related Party      6,060,606    3,181,818    2,878,788    163,657      
       34,630,305    12,757,576    21,872,729   $937,986